Alkermes Plc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Alkermes Plc with three other
pharmaceutical manufacturers in Europe:
of the United Kingdom
sales of £839.48 million [US$1.07 billion]
of which 100%
was Buprenorphine Based Drugs),
(807.12 million Euro [US$921.37 million]
of which 47%
was X-rays), and
based in France
(861.88 million Euro [US$983.88 million]
of which 55%
was Companion Animals).